Clinical Trials in Baltimore

Showing 10821-10840 of 23,476 trials

RCT of a Polyherbal Dietary Supplement for Prediabetes

NCT03388762

The primary purpose of this study is to evaluate the impact of a polyherbal dietary supplement (Designs for Health - GlucoSupreme™ Herbal) on markers of glycemic control and other structure/function outcomes among a sample of prediabetic adults. A 12-week randomized, double-blinded, placebo-controlled clinical trial will be conducted to achieve the purpose of this study. The research team hypothesizes that GlucoSupreme™ Herbal will improve a variety of validated markers of glycemic control that are commonly used in clinical practice more effectively than placebo.

Prediabetic State

University of Maryland, Baltimore39 participantsStarted Dec 2017

Baltimore, Maryland, United States • Baltimore, Maryland, United States • Baltimore, Maryland, United States +1 more locations

TERMINATEDPhase 2< 1 mile

Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects

NCT01177540

The purpose of this study is to provide data on the activity of a standard daunorubicin, cytarabine, and etoposide (ADE) induction plus epigenetic priming with decitabine as assessed by standard measures of complete remission (CR), leukemia free survival (LFS) and overall survival (OS), as well as, on minimal residual disease (MRD). It will also provide necessary data on the safety and Pharmacokinetics (PK) of decitabine in pediatric patients that is currently unavailable.

Pediatric Acute Myelogenous Leukemia (AML)

Eisai Inc.25 participantsStarted Mar 2011

Phoenix, Arizona, United States • Madera, California, United States • Aurora, Colorado, United States +19 more locations

RCT of a Polyherbal Dietary Supplement for Prediabetes

Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects

Find Trials by Condition in Baltimore

Study to Evaluate Vadadustat for the Correction of Anemia in Participants With Non-dialysis-dependent Chronic Kidney Disease

CentriMag Ventricular Assist System in Treating Failure-to-Wean From Cardiopulmonary Bypass

MOMENTUM 3 Continued Access Protocol

MOMENTUM 3 IDE Clinical Study Protocol

RE-sensitizing With Supraphysiologic Testosterone to Overcome REsistance (The RESTORE Study)

Thoratec HeartMate II Left Ventricular Assist System (LVAS) for Bridge to Cardiac Transplantation

SHIELD II Clinical Investigation

Personalized Research on Diet in Ulcerative Colitis and Crohn's Disease

Losartan for Patients With COVID-19 Requiring Hospitalization

Dose Ranging Study To Assess Efficacy, Safety and Tolerability Of PF-06700841 Topical Cream In Psoriasis

Study of Nivolumab (BMS-936558) in Patients With Advanced or Metastatic Squamous Cell Nonsmall-cell Lung Cancer Who Have Received At Least 2 Prior Systemic Regimens

Study of AGN-190584 Eye Drops to Assess Safety and Efficacy in Participants Aged 40-80 Years With Pseudophakic Presbyopia

Safety Study of the VEGA UV-A System to Treat Ectasia

Safety and Effectiveness Study of the VEGA UV-A System for Cross-linking in Eyes With Keratoconus and Ectasia

Dose-Ranging Study for Prolonged Postoperative Analgesia in Subject Undergoing Total Knee Arthroplasty

CentriMag RVAS U.S. Post-approval Study Protocol

Clinical Decision Support to Implement ED-initiated Buprenorphine for OUD

A Study for Long-term Follow-up of Hemophagocytic Lymphohistiocytosis (HLH) Participants Who Received Treatment With Emapalumab (NI-0501), an Anti-interferon Gamma Monoclonal Antibody